The toxin of Clostridium butyricum strains isolated from two infants with botulism is neutralized by antitoxin for type E botulinum toxin. This toxin and that of a C. botulinum type E strain were purified by the same protocol. Both toxins were Mr 145,000 proteins which, when activated with trypsin, were composed of an H subunit ofMr 105,000 and an L subunit Of Mr 50,000. The activated specific toxicity of purified butyricum toxin based on an intravenous assay was 2 x 108 mouse 50% lethal doses (LD50s)/mg of protein, but that based on an intraperitoneal assay was 7 x 107 LD50S/mg, compared with 6 x 107 LD50s/mg for type E toxin as determined by both methods. Immunodiffusion tests with antitoxin raised with type E toxin indicated that the two toxins were serologically very similar except for a spur formed by type E toxin. The close similarities of the two toxins suggest that toxigenic C. butyricum could arise when a wild-type strain, which is normally nontoxigenic, acquires the toxin gene of a C. botulinum type E strain.
Cultures. Toxigenic C. butyricum 5839 and 5521, wild-type nontoxigenic C. butyricum ATCC 19398, and C. botulinum type E strain 5545 were kindly provided by C. L. Hatheway, Centers for Disease Control, Atlanta, Ga. They were grown for 5 days at 30°C in cooked meat medium (Difco Laboratories, Detroit, Mich.) and then stored at -20°C as stock cultures. Purification. Toxins were produced and purified by the method previously described for C. botulinum type E toxin (6) . The production medium was 12 liters of Trypticase (BBL Microbiology Systems, Cockeysville, Md.)-peptone glucose-yeast extract-sodium thioglycolate, adjusted to pH 6.5 . Cells obtained during 55 h of incubation at 30°C were collected and washed with 0.05 M acetate buffer, pH 5.0, both by centrifugation. Toxin in the washed cells was then extracted with 0.2 M phosphate buffer, pH 6 .0.
Purification consisted of (i) chromatographing the extracted toxin on DEAE-Sephadex A-50 (Pharmacia Fine Chemicals, Piscataway, N.J. [Div. Pharmacia, Inc.]) to remove nucleic acid, (ii) treating the pool of toxic percolate fractions on CM-Sepharose CL-6B (Pharmacia) to recover the toxin that is noncovalently associated with a similar size nontoxic protein (toxic complex; reference 12), and (iii) chromatographing the pooled toxic percolate fractions of the previous step on DEAE-Sephacel (Pharmacia) at alkaline pH to separate toxic from nontoxic proteins with an NaCl gradient (6) .
Polyacrylamide gel electrophoresis. The Mrs of proteins were determined by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (6) . When needed, disulfides were reduced by heating the sample in a boiling water bath for 5.0 min in the presence of 4.0% 2-mercaptoethanol.
Protein and toxicity assays. Protein was determined spectrophotometrically by using an A278 of 1.63 for 1 mg of sample per ml in 0.03 M phosphate buffer, pH 6 ferent stages of purification are shown in Fig. 4A . The two DEAE-Sephadex toxins showed two prominent and several light bands (Fig. 4A, lanes 1 and 2) . Since CM-Sepharose toxins showed essentially only the two prominent bands (lanes 3 and 4) and had almost all of the toxicity applied to the column, the toxins consisted of bimolecular complexes made of an Mr 145,000 toxin and an Mr 127,000 nontoxic protein. The final chromatography on DEAE-Sephacel (lanes 5 and 6) separated the two proteins of the complex, with the NaCI gradient eluting pure toxin in the first protein peak and the nontoxic protein in the second peak (Fig. 3) . When activated with trypsin and treated with 2-mercaptoethanol, the purified toxin samples showed only Mr 105,000 H subunits and Mr 50,000 L subunits (Fig. 4A, lanes 7 and 8) .
The Mr of intact butyricum toxin and its H and L subunits therefore appeared comparable to those of type E toxin. Furthermore, when mixtures of the two purified toxins were electrophoresed, the mobilities of the intact molecules and the subunits of the two toxins were indistinguishable (Fig.  4B, lanes 1 and 2) Toxicity. Trypsinization of all toxin preparations increased toxicity about 200-fold, but butyricum and type E toxins reached maximal toxicities at different incubation times. With a 2:1 (wt/wt) toxin-enzyme ratio and a temperature of 35°C, full activation of butyricum toxin occurred in less than 5 min, while type E toxin required at least 20 min.
Although the phenomenon did not occur with less purified preparations, the toxicity of purified butyricum toxin depended on the assay method such that the i.v. assayed value was about three times higher than the intraperitoneally determined toxicity ( Table 1) . The difference could not be eliminated by using other toxin-enzyme ratios and incubation times.
Even the higher toxicity of purified toxin obtained with the i.v. assay was less than that theoretically possible; specific toxicity was only 1.1 times that of CM-Sepharose toxin instead of the twofold difference expected when the nontoxic protein of the bimolecular complex is removed. Type E toxin was different in this respect; the last purification step increased its toxicity to the expected degree and, when it was purified, it showed comparable toxicities in the two assay methods (6) . The trypsinization times needed for full activation also indicated some difference between the two purified toxins.
Nevertheless, when i.v. assayed toxicities were used, the specific toxicity calculated for butyricum toxin was about three times that of type E toxin (22 x 107 versus 6 x 107/mg of protein). As previously reported for type E toxin, the specific toxicity of butyricum toxin on the basis of the i.v. assayed LD50 was about 15% higher when the calculation used protein amounts determined by the Bio-Rad method instead of by spectrophotometry.
Antigenicity. When reacted with antitoxin raised against type E toxin, each of the two toxins formed a single immune precipitate line which joined in a line of identity except for a spur formed by type E toxin (Fig. SA) . The spur indicated that the known type E toxin has an antigen that is absent in butyricum toxin. Antitoxin raised against butyricum toxin was not available, so that it was not possible to determine whether butyricum toxin has an antigen not shared by type E toxin.
The Mr 127,000 nontoxic proteins (Fig. SB) in the bimolecular complexes of the two toxins, recovered in the second protein eluted from DEAE-Sephacel (Fig. 3) , were antigenically indistinguishable (Fig. SB) . This nontoxic protein is apparently not produced by nontoxigenic C. butyricum, since the concentrated cell extract of strain ATCC 19398 did not form a precipitate line in the immunodiffusion test (data not shown). The absence of a precipitate line also indicated that nontoxigenic C. butyricum does not produce a protein whose antigens include one that is serologically related to an antigen in type E botulinum toxin.
The present results indicate that the toxigenic C. butyricum strains produce a toxin very similar, although not identical, to the toxin of a known C. botulinum type E strain. Since C. butyricum strains are normally nontoxigenic, the similarities of the toxins make it possible to suggest that the toxigenic C. butyricum strains resulted when nontoxigenic strains acquired the toxin gene of C. botulinum type E. This interspecies transfer of genetic material probably includes the gene for the nontoxic protein with which type E botulinum toxin normally forms bimolecular complexes.
